See more : TCC Steel Corp. (002710.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Jushi Holdings Inc. (JUSHF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jushi Holdings Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Starwin Media Holdings Inc. (SWMD) Income Statement Analysis – Financial Results
- DP Aircraft I Limited (DPA.L) Income Statement Analysis – Financial Results
- Landi Renzo S.p.A. (0ND3.L) Income Statement Analysis – Financial Results
- Infomedia Press Limited (INFOMEDIA.NS) Income Statement Analysis – Financial Results
- AltC Acquisition Corp. (ALCC) Income Statement Analysis – Financial Results
Jushi Holdings Inc. (JUSHF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jushico.com
About Jushi Holdings Inc.
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabidiol supplements, tinctures, capsules, softgels, and topicals under The Bank, The Lab, Nira+ Medicinals, Seche, Tasteology, and Nira brands. As of June 6, 2022, it operated 33 BEYOND/HELLO retail locations. The company was incorporated in 2007 and is headquartered in Boca Raton, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 269.45M | 284.28M | 209.29M | 80.77M | 10.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 153.22M | 188.81M | 121.92M | 37.70M | 5.41M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 116.23M | 95.48M | 87.37M | 43.07M | 4.82M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 43.14% | 33.59% | 41.75% | 53.32% | 47.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 156.17M | 101.69M | 46.42M | 33.33M | 127.15K | 80.36K | 315.63K | 914.63K | 1.23M | 1.42M | 3.04M | 1.75M | 26.77K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.96K | 0.00 | 113.04K | 194.52K | 165.85K | 228.23K | 0.00 | 0.00 |
| SG&A | 110.47M | 156.17M | 101.69M | 46.42M | 33.33M | 127.15K | 80.36K | 336.59K | 914.63K | 1.23M | 1.42M | 3.21M | 1.98M | 26.77K | 37.12K |
| Other Expenses | 8.57M | -482.00K | 6.84M | 5.07M | 2.16M | 0.00 | 0.00 | 1.17K | 37.70K | 279.10K | 134.92K | 155.94K | 30.32K | 0.00 | 0.00 |
| Operating Expenses | 119.05M | 156.17M | 108.53M | 51.49M | 35.50M | 127.15K | 80.36K | 337.76K | 952.32K | 1.51M | 1.55M | 3.36M | 2.01M | 26.77K | 37.12K |
| Cost & Expenses | 272.26M | 344.97M | 230.45M | 89.19M | 40.90M | 127.15K | 80.36K | 337.76K | 952.32K | 1.51M | 1.55M | 3.36M | 2.01M | 26.77K | 37.12K |
| Interest Income | 0.00 | 142.00K | 243.00K | 231.00K | 378.49K | 1.07M | 0.00 | 1.70K | 12.51K | 28.83K | 51.43K | 92.24K | 0.00 | 156.00 | 0.00 |
| Interest Expense | -36.97M | 45.73M | 31.20M | 19.13M | 3.25M | 0.00 | 0.00 | 1.70K | 12.51K | 28.83K | 51.43K | 92.24K | 2.66K | 156.00 | -37.12K |
| Depreciation & Amortization | 27.08M | 26.49M | 8.41M | 4.43M | 2.23M | -15.37K | 7.72K | -3.40M | 15.12K | 17.26K | 14.79K | 18.46K | 11.69K | -156.00 | 0.00 |
| EBITDA | 30.91M | -121.65M | -10.89M | -7.10M | -38.64M | -142.51K | -72.64K | -3.74M | -944.29K | -1.50M | -1.50M | -3.31M | -2.00M | -26.77K | -37.12K |
| EBITDA Ratio | 11.47% | -12.15% | -5.20% | -8.79% | -239.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -2.82M | -60.69M | -20.36M | -8.42M | -30.67M | -127.15K | -80.36K | -337.76K | -952.32K | -1.50M | -1.58M | -3.40M | -2.01M | -26.62K | -37.12K |
| Operating Income Ratio | -1.05% | -21.35% | -9.73% | -10.43% | -299.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -31.09M | -113.34M | 88.22M | -185.34M | 7.89M | 15.37K | 7.72K | -3.40M | 19.60K | 28.83K | 48.10K | 92.24K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -33.91M | -193.88M | 52.45M | -201.47M | -26.26M | -111.78K | -72.64K | -3.74M | -932.72K | -1.47M | -1.53M | -3.31M | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | -12.58% | -68.20% | 25.06% | -249.42% | -256.73% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 32.39M | 8.45M | 31.09M | 10.40M | 4.51M | -15.37K | -7.72K | 3.40M | -39.20K | -75.87K | -33.58K | -115.26K | -5.31K | -312.00 | 37.12K |
| Net Income | -66.30M | -202.32M | 20.25M | -211.87M | -30.77M | -111.78K | -64.92K | -7.14M | -932.72K | -1.47M | -1.53M | -3.31M | -2.01M | -26.62K | -37.12K |
| Net Income Ratio | -24.60% | -71.17% | 9.68% | -262.30% | -300.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.34 | -1.06 | 0.12 | -2.13 | -0.37 | -0.05 | -0.03 | -2.97 | -0.39 | -0.61 | -0.64 | -1.37 | -1.08 | -0.40 | -0.68 |
| EPS Diluted | -0.34 | -0.99 | -0.41 | -2.13 | -0.37 | -0.05 | -0.03 | -2.97 | -0.39 | -0.61 | -0.64 | -1.37 | -1.08 | -0.40 | -0.68 |
| Weighted Avg Shares Out | 194.77M | 190.02M | 170.29M | 99.56M | 82.06M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 1.85M | 66.67K | 54.96K |
| Weighted Avg Shares Out (Dil) | 194.77M | 204.24M | 201.61M | 99.56M | 82.06M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 2.41M | 1.85M | 66.67K | 54.96K |
Cannabis Investing 2024: Here Are 3 Marijuana Stocks To Watch
Marijuana stock investors are prepping for another long year. During 2023 the trading that occurred was still volatile and there was not much change. Yet the cannabis industry as a whole continued to grow and blossom. In 2023 we saw...
The Best Marijuana Stocks to Watch in December 2023
As December 2023 continues, investors are keenly watching the marijuana stock market, buoyed by the burgeoning US cannabis industry. Recent statistics highlight a remarkable growth trajectory. In 2023, the industry's revenue is projected to surpass $20 billion, a significant increase...
Cannabis Investors Are Watching These Marijuana Stocks
Marijuana stock investors are looking for more ways to prepare for 2024. New and seasoned investors want to head into the new year with a strong portfolio. Yet this is a tough task to complete only due to how the...
Jushi Holdings Inc. Announces Filing of Preliminary Base Shelf Prospectus
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BOCA RATON, Fla., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF), a vertically integrated, multi-state...
3 Marijuana Stocks For Your Cannabis Watchlist Today
2024 is already looking like a promising time for marijuana stock investors. Every year the cannabis industry continues to grow and evolve. Through this process, we see moments that are both good and bad. The path that legal cannabis has...
Jushi Holdings Inc. Announces Option Re-Pricing Program
BOCA RATON, Fla., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, is pleased to announce that an independent committee of its board of directors has...
Jushi Holdings Inc. (JUSHF) Q3 2023 Earnings Call Transcript
Jushi Holdings Inc. (OTCQX:JUSHF) Q3 2023 Earnings Conference Call November 14, 2023 5:00 PM ET Company Participants Jon Barack - President Lisa Forman - Director, Investor Relations James Cacioppo - Chairman and Chief Executive Officer Michelle Mosier - Chief Financial...
Jushi Holdings Inc. Reports Third Quarter 2023 Financial Results
Gross Profi t Margin Remained Steady in Q3 2023 at 43.6% on Continued Growth of Jushi-Branded Product Sales
Cannabis Bulls: Top US Marijuana Stocks Blaze a Trail with Strong Weekly Gains
As the landscape of the United States cannabis industry continues to evolve, investors are closely eyeing top marijuana stocks that are currently in the spotlight for their earnings reports. With the gradual legalization of marijuana in various states, these financial...
Cannabis Investing Today: 3 Top Marijuana Stocks To Keep An Eye On 2024
The current focus for marijuana stock investors is preparing for the new year. There is only a little bit of time before 2024 begins and this year will be big for cannabis. Not just with reform but as a whole...
Source: https://incomestatements.info
Category: Stock Reports